29 Feb 2016 Date | | - Cons. EPS | - EPS |
30 Nov 2015 Date | | - Cons. EPS | - EPS |
31 Aug 2015 Date | | - Cons. EPS | - EPS |
28 Feb 2015 Date | | - Cons. EPS | - EPS |
30 Nov 2014 Date | | - Cons. EPS | - EPS |
29 Feb 2016 Date | | - Cons. EPS | - EPS |
30 Nov 2015 Date | | - Cons. EPS | - EPS |
31 Aug 2015 Date | | - Cons. EPS | - EPS |
28 Feb 2015 Date | | - Cons. EPS | - EPS |
30 Nov 2014 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Ms. Nataliia Petranetska CEO | OTC PINK Exchange | US83084W1045 ISIN |
US Country | 1 Employees | - Last Dividend | 23 May 2014 Last Split | - IPO Date |